Suppr超能文献

胃平滑肌细胞上降钙素基因相关肽受体的特性研究

Characterization of receptors for calcitonin gene-related peptide on gastric smooth muscle cells.

作者信息

Maton P N, Sutliff V E, Zhou Z C, Collins S M, Gardner J D, Jensen R T

机构信息

Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.

出版信息

Am J Physiol. 1988 Jun;254(6 Pt 1):G789-94. doi: 10.1152/ajpgi.1988.254.6.G789.

Abstract

Rat calcitonin gene-related peptide (rat CGRP) and related peptides did not cause contraction of gastric smooth muscle cells; however, preincubation with rat CGRP or human CGRP inhibited smooth muscle contraction caused by carbachol. Rat CGRP and human CGRP were equipotent in opposing contraction with a half-maximal effect produced by 0.1 nM, but rat calcitonin-adjacent peptide (rat CAP) and human calcitonin had no effect. Rat CGRP caused an increase in cellular adenosine 3',5'-cyclic monophosphate (cAMP) of 60%, which was augmented to 155% with 1 mM isobutyl methylxanthine (IBMX). IBMX did not influence the sensitivity of the muscle cells to rat CGRP to increase cAMP, the half maximal effect being produced by 0.4 nM in the presence or absence of IBMX. Rat CGRP and human CGRP were equipotent for stimulating cAMP, but rat CAP and human calcitonin had no effect. Binding of 125I-CGRP was temperature dependent, saturable, reversible, and specific. Rat CGRP and human CGRP were equipotent at inhibiting binding of 125I-CGRP and rat CAP, and human calcitonin did not inhibit binding. For rat CGRP and human CGRP, the dose-response curves for binding of 125I-CGRP were broad, and both peptides accelerated the rate of dissociation of bound 125I-CGRP. Computer analysis of dose-response curves demonstrated two classes of binding sites for CGRP, one with a high affinity (Kd 3 nM) and another with low affinity (Kd 3,700 nM). Our results indicate that CGRP interacts with previously undescribed receptors on gastric smooth muscle cells to increase cellular cAMP and inhibit contraction.

摘要

大鼠降钙素基因相关肽(大鼠CGRP)及相关肽不会引起胃平滑肌细胞收缩;然而,用大鼠CGRP或人CGRP预孵育可抑制卡巴胆碱引起的平滑肌收缩。大鼠CGRP和人CGRP在对抗收缩方面效力相当,0.1 nM可产生半数最大效应,但大鼠降钙素毗邻肽(大鼠CAP)和人降钙素则无此作用。大鼠CGRP使细胞内3',5'-环磷酸腺苷(cAMP)增加60%,加入1 mM异丁基甲基黄嘌呤(IBMX)后增加至155%。IBMX不影响肌肉细胞对大鼠CGRP增加cAMP的敏感性,有无IBMX存在时,半数最大效应均由0.4 nM产生。大鼠CGRP和人CGRP在刺激cAMP方面效力相当,但大鼠CAP和人降钙素无此作用。125I-CGRP的结合具有温度依赖性、可饱和性、可逆性和特异性。大鼠CGRP和人CGRP在抑制125I-CGRP结合方面效力相当,大鼠CAP和人降钙素则无抑制结合作用。对于大鼠CGRP和人CGRP,125I-CGRP结合的剂量反应曲线较宽,两种肽均加速结合的125I-CGRP的解离速率。对剂量反应曲线的计算机分析表明,CGRP存在两类结合位点,一类具有高亲和力(解离常数Kd为3 nM),另一类具有低亲和力(Kd为3700 nM)。我们的结果表明,CGRP与胃平滑肌细胞上以前未描述的受体相互作用,以增加细胞内cAMP并抑制收缩。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验